APA (7th ed.) Citation

Libri, V., Yandim, C., Athanasopoulos, S., Loyse, N., Natisvili, T., Law, P. P., . . . Festenstein, R. (2014). Epigenetic and neurological effects and safety of high-dose nicotinamide in patients with Friedreich's ataxia: An exploratory, open-label, dose-escalation study. The Lancet (British edition), 384(9942), 504-513. https://doi.org/10.1016/S0140-6736(14)60382-2

Chicago Style (17th ed.) Citation

Libri, Vincenzo, et al. "Epigenetic and Neurological Effects and Safety of High-dose Nicotinamide in Patients with Friedreich's Ataxia: An Exploratory, Open-label, Dose-escalation Study." The Lancet (British Edition) 384, no. 9942 (2014): 504-513. https://doi.org/10.1016/S0140-6736(14)60382-2.

MLA (9th ed.) Citation

Libri, Vincenzo, et al. "Epigenetic and Neurological Effects and Safety of High-dose Nicotinamide in Patients with Friedreich's Ataxia: An Exploratory, Open-label, Dose-escalation Study." The Lancet (British Edition), vol. 384, no. 9942, 2014, pp. 504-513, https://doi.org/10.1016/S0140-6736(14)60382-2.